Hives, also called urticaria, are red, itchy welts that can appear anywhere on the body and range from mild to severe. In ...

There are many different types of hives -- urticaria -- with many different causes. In most cases, these puffy, red, or skin-colored bumps and wheals appear suddenly due to an allergic reaction to ...

Patients with chronic spontaneous urticaria experienced substantial reductions in hives and itch with briquilimab through 16 ...

P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, ...

The mainstay of treatment for urticaria is oral antihistamines as they reduce itch, wheal duration and numbers. Management is better achieved by taking antihistamines daily, not just when the ...

The objective of this study was to evaluate the cost effectiveness of levocetirizine, a first-line treatment for urticaria. Methods: Data were collected from two placebo-controlled trials and from ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

Omalizumab biosimilar is under clinical development by Mabpharm and currently in Phase III for Chronic Urticaria Or Hives. According ...

Jasper Therapeutics (JSPR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Silvan ...

Analyst Silvan Tuerkcan of JMP Securities reiterated a Buy rating on Allakos (ALLK – Research Report), with a price target of $3.00.Stay Ahead ...

Barzolvolimab: A Promising Treatment for Urticaria Barzolvolimab is an anti-KIT monoclonal antibody designed to treat CSU and other mast cell-driven diseases. Its mechanism of action involves ...

INF-904 is under clinical development by InflaRx and currently in Phase I for Chronic Urticaria Or Hives. According to GlobalData, Phase I drugs for Chronic Urticaria Or Hives have an 87% phase ...